19 Oct OEM vs ODM Private Label Pet Supplements: Which Manufacturing Model Is Better for New Brands?

The pet supplements market continues to expand as more consumers treat pets as family members and pay closer attention to preventive wellness, healthy aging, mobility, digestion, skin and coat condition, and emotional well-being. Market forecasts differ in methodology and geographic coverage, but several industry studies project continued global growth from 2026 into the next decade. Joint health, digestive health, skin and coat care, calming support, and healthy-aging products remain important areas of product development.

Younger pet owners are also showing greater interest in transparent labels, recognizable ingredients, personalized pet nutrition, and science-backed supplement formulations. Instead of choosing products based only on attractive packaging, these customers increasingly want to understand why an ingredient is included, how the product is manufactured, and whether its identity, safety, purity, and potency have been properly controlled.

These changes create opportunities for established companies and new entrepreneurs that want to launch private label pet supplements. However, building a successful pet supplement brand involves more than selecting a formula and adding a label. Companies must make decisions about active ingredients, supplement type, delivery formats, taste, packaging, minimum order quantities, quality assurance, testing, claims, regulatory compliance, pricing, lead times, and future production scale.

One of the first questions is whether to choose OEM pet supplements based on a customized formula or an ODM solution based on a manufacturer-developed product. Neither model is automatically better. The right option depends on the brand’s budget, experience, customer needs, desired level of differentiation, target market, and long-term business strategy.

1. Understanding OEM, ODM, and Private Label Pet Supplement Manufacturing

1.1 What Are OEM Pet Supplements and Custom Formulations?

OEM usually refers to Original Equipment Manufacturing. In the pet supplement industry, OEM pet supplements are generally produced according to a formula, product specification, or detailed concept provided by the customer. The brand may already own a completed formula, or it may ask a contract manufacturing partner to help convert an initial concept into a stable and scalable product.

For example, a company may want to develop a joint health pet supplement for senior dogs. Its proposed formula could contain collagen peptides, turmeric, selected mushroom extracts, vitamins, minerals, and other active ingredients associated with mobility and healthy aging. The company may also request a specific flavor, serving size, package count, product shape, and clean-label positioning.

The manufacturer must then determine whether the proposed ingredients are suitable for the intended animals and permitted for the destination market. It must also evaluate ingredient compatibility, dosage, taste, processing behavior, shelf-life expectations, and the physical limitations of the selected delivery format.

Collagen peptides, for instance, are increasingly used in pet nutrition products positioned for joint, connective tissue, skin, and coat support. Turmeric is commonly included in formulas intended to support normal mobility and occasional discomfort, although the product’s claims must remain within the applicable regulatory boundaries. Adaptogens and botanical ingredients are also appearing in calming formulas for pets experiencing occasional stress, but their suitability, safety, dosage, and supporting evidence must be reviewed carefully for the target species.

Mushroom extracts are another growing area of innovation. Certain formulations use mushroom-derived components in products positioned for immune, cognitive, or healthy-aging support in senior pets. However, “mushroom extract” is not a single standardized ingredient. Species, extraction method, concentration, marker compounds, contaminants, and supporting evidence can differ significantly. A responsible manufacturer should therefore evaluate the specific extract rather than approve a formula based only on the ingredient name.

Custom formulation gives the brand greater control over the formula, active ingredients, nutrient levels, delivery format, flavor profile, and market positioning. This can help protect brand integrity and create a clearer reason for customers to choose the product instead of one of the dozens of similar supplements on the market.

OEM development is especially valuable when a company has identified specific customer needs or wants to serve a defined group of animals. Personalized pet nutrition is becoming more visible as brands develop products for particular breeds, body sizes, life stages, lifestyles, and wellness outcomes. Some companies are also exploring DNA testing services for pets as a source of information for personalized nutrition recommendations.

However, DNA-based pet nutrition remains an emerging field. Genetic results should not automatically be treated as proof that a pet requires a specific supplement. Product recommendations should be based on credible evidence and, where appropriate, professional veterinary input. Personalization can be a meaningful area of innovation, but it should not become an excuse for unsupported claims.

OEM pet supplement manufacturing normally requires more time and investment than selecting a stock formula. A custom product may need several sample rounds to improve taste, aroma, texture, color, flow, hardness, moisture, and stability. Ingredients that perform well in a powder may not work equally well in soft chews or chewable tablets. Bitter botanicals, high mineral levels, oily components, probiotics, and moisture-sensitive nutrients can create additional formulation challenges.

Custom products may also require higher minimum order quantities because the manufacturer must purchase specialized ingredients or complete dedicated production and cleaning procedures. Testing requirements, packaging development, custom tooling, and production losses can further affect cost and lead times.

For this reason, customization should serve a clear commercial or technical purpose. Adding more active ingredients does not automatically create a better pet supplement. If the formula becomes too expensive, difficult to manufacture, unstable, or unacceptable in taste, the additional complexity can reduce rather than improve the product’s chance of success.

1.2 How ODM and Private Label Pet Supplements Simplify Market Entry

ODM stands for Original Design Manufacturing. Under this model, the manufacturer provides the product design or formula foundation, while the customer markets and sells the finished product under its own brand.

In practice, industry terminology is not always consistent. Some pet supplement manufacturers use ODM, white label, and private label to describe similar services. Others use private label as a broad category that includes both stock formulas and customized products. New brands should therefore ask each prospective partner to explain exactly what its service includes rather than relying only on the terminology.

ODM and stock-formula private label pet supplements can simplify market entry because much of the technical development has already been completed. The manufacturer may already have an established formula, approved suppliers, defined production parameters, available packaging components, and standard quality specifications.

The customer can focus on its brand identity, packaging design, label, sales strategy, marketing, and distribution. Depending on the manufacturer’s capabilities, the business may also be able to adjust the flavor, serving count, container size, label design, or selected components without redeveloping the entire formula.

This approach is often more cost effective than starting with a fully custom product. The manufacturer may purchase common ingredients for several production orders, which can reduce procurement pressure and improve production efficiency. Established manufacturing procedures can also make pricing and lead times more predictable.

MOQ requirements vary considerably. Some manufacturers advertise minimum orders around 800 finished units, while certain stock soft chews may start near 500 units. These figures should be treated only as examples, not industry standards. Actual MOQ depends on the formula, supplement type, ingredient purchasing requirements, packaging, production line, testing plan, and manufacturing facility.

A low unit MOQ can also be misleading if labels, jars, cartons, scoops, or ingredients have higher supplier minimums. Brands should ask for a complete MOQ breakdown covering both finished products and packaging components.

ODM is particularly useful for companies that want to test the market before investing in a proprietary formula. A startup may launch one or two private label pet products, measure sales, collect customer feedback, and identify repeat-purchase behavior. This information can later support the development of a semi-custom or fully customized product.

The main limitation is differentiation. A stock formula may also be available to other companies, so the brand cannot depend entirely on the product composition to stand out. It must create value through positioning, education, packaging, service, distribution, pricing, community, or a clearly defined audience.

Before proceeding, the company should also confirm formula ownership and exclusivity. In most ODM or white-label arrangements, the manufacturer retains ownership or control of the base formula. The customer owns its trademarks and packaging artwork but may not own the formulation itself. Understanding these boundaries is critical for maintaining long-term brand integrity.

2. Comparing Formula, Delivery Formats, Quality, Cost, and Lead Times

2.1 Choosing the Right Pet Supplement Formula and Delivery Formats

The choice between OEM and ODM should not be separated from the delivery format. Various delivery formats create different requirements for formulation, equipment, taste, packaging, testing, stability, production cost, and customer acceptance.

Soft chews are among the most popular formats for dogs because they can be incorporated into a daily routine and presented as a treat-like experience. They are widely used for joint health, calming support, digestive wellness, skin and coat care, immune support, and multinutrient formulas.

Soft chews are also improving as pet supplement manufacturing technology evolves. Brands increasingly request cleaner ingredient lists, fewer unnecessary fillers, better taste, more consistent texture, and improved stability. However, creating a clean-label soft chew is not simply a matter of removing components. Binders, humectants, preservatives, flavor systems, and processing aids may perform important functions related to texture, microbial control, and shelf life.

Probiotics are commonly used in digestive health formulas because the gut microbiome is increasingly recognized as part of overall wellness. Nevertheless, probiotics are not automatically “essential” in every pet supplement. The microorganism strain, viable count, stability, storage conditions, manufacturing temperature, and expected potency at the end of shelf life all matter.

A probiotic may lose viability if it is exposed to excessive heat, moisture, or pressure during production. Manufacturers must consider whether the organisms should be added after a heating stage, protected through specialized technology, or delivered in a different format. A label claim at the time of production is less useful if the product cannot maintain the intended viable count throughout its stated shelf life.

Chewable tablets provide another scalable option. They can offer accurate unit weight, efficient packaging, and good physical stability. Industrial tablet presses can produce very large volumes, and certain high-speed equipment configurations may reach production rates approaching hundreds of thousands of tablets per hour, including quoted maximums near 490,000 tablets per hour.

That figure should not be interpreted as the normal output for every pet supplement project. Actual production speed depends on tablet size, shape, formulation flow, compression characteristics, tooling, equipment model, quality-control requirements, and downtime. A manufacturer’s theoretical equipment capacity is different from its practical finished-product output.

Taste and hardness are especially important for chewable tablets. A tablet may pass manufacturing tests but still perform poorly in the market if dogs or cats refuse to consume it. Palatability should therefore be considered during formula development rather than after commercial production has begun.

Powders can be mixed with food and may be suitable for products requiring a larger serving size. They can be cost effective and provide flexibility in the use of proteins, fibers, probiotics, collagen peptides, minerals, and other nutrients. However, manufacturers must control moisture, flow, dust, ingredient separation, flavor distribution, scoop accuracy, and packaging seal integrity.

Liquids may be convenient for smaller pets, animals that reject tablets, or customers who want an adjustable serving size. The development process must address viscosity, microbial safety, suspension stability, taste, filling accuracy, leakage risk, and container compatibility.

Topical formats are also emerging for targeted applications, including skin, paw, coat, and localized joint-support routines. These products may include balms, sprays, gels, or other external-use formats. However, topical animal products may fall into a different regulatory category depending on their ingredients, claims, intended use, and destination market. A manufacturer experienced only in ingestible supplements may not have the facility, documentation, or regulatory knowledge required to produce topical products.

Cats create additional challenges because their taste, smell, texture, and feeding preferences can differ substantially from those of dogs. A successful dog soft chew cannot automatically be converted into a product for cats. Brands should confirm that the manufacturer has relevant formulation knowledge and suitable manufacturing capabilities for the intended animals.

ODM may be the better solution when an established formula and delivery format already match the target customer. OEM becomes more valuable when the brand needs a specific nutrient profile, ingredient combination, flavor, texture, serving size, or functional positioning that is not available through existing private label pet products.

2.2 Quality Assurance, Packaging, Pricing, and Production Lead Times

Quality assurance is critical in both OEM and ODM pet supplement manufacturing. A custom formula is not automatically higher quality because it is unique, and a stock formula is not automatically safe simply because it has been manufactured previously.

A reliable manufacturing partner should follow documented good manufacturing practices and quality standards appropriate to the products it produces. The quality system should cover supplier approval, raw material specifications, incoming inspection, identity controls, batch records, sanitation, traceability, in-process checks, finished-product testing, complaint management, adverse event handling, and recall procedures.

Certificates of Analysis, commonly called COAs, provide batch-specific information about raw materials or finished products. Depending on the material and specification, a COA may report identity, purity, potency, microbiological results, heavy metals, physical properties, or other quality parameters.

However, a supplier-issued COA does not independently prove that every reported result is accurate. A robust quality assurance program should qualify suppliers, review their testing methods, conduct risk-based verification, and use qualified internal or third party testing where appropriate. Brands should ask which COA results are verified and how frequently verification is performed.

Third party testing can provide additional confidence, but the testing plan must match the formula and its risks. A basic microbial test does not verify active ingredient potency, and a potency test does not confirm the absence of every possible contaminant. Testing may need to cover identity, microbiological safety, heavy metals, nutritional components, active ingredients, physical specifications, stability, or label claims.

In the United States, products marketed as pet supplements do not have the same standalone legal category as human dietary supplements. Depending on their ingredients, intended use, presentation, and claims, they are generally regulated within the animal-food or animal-drug framework. Under the Federal Food, Drug, and Cosmetic Act, animal food must be safe, produced under sanitary conditions, free from harmful substances, and truthfully labeled. Ingredients must also be legally suitable for their intended use. Disease-treatment or prevention claims can cause a product to be treated as an animal drug rather than an animal food.

The National Animal Supplement Council is an industry organization rather than a federal regulator. Companies permitted to display the NASC Quality Seal must pass an independent quality audit and maintain ongoing compliance with the program’s requirements. These include documented quality procedures, labeling controls, adverse event reporting, random independent product testing, and annual training.

It is therefore more accurate to say that the NASC Quality Seal demonstrates participation in and compliance with the NASC Quality Program. It should not be described as universal government approval or as proof that every individual product has been evaluated for effectiveness.

FSSC 22000 is another quality credential that may be relevant when evaluating pet supplement manufacturers. It is a food safety management system certification scheme that can cover animal feed and pet food manufacturing within its applicable scopes. It supports systematic hazard analysis and food safety controls. However, FSSC 22000 is a management-system certification, not a certification that guarantees the efficacy of an individual pet supplement.

Packaging also affects safety, quality, cost, and brand perception. Bottles, jars, pouches, scoops, labels, liners, induction seals, desiccants, cartons, and shipping cases must be compatible with the formula. Packaging should protect the product from moisture, oxygen, light, contamination, leakage, and physical damage while remaining practical for customers.

ODM pricing is usually easier to estimate because the formula, process, testing plan, and standard packaging are already defined. OEM pricing may change during development as the manufacturer confirms ingredient costs, production losses, sample performance, laboratory requirements, and final packaging specifications.

Flexible batch sizes are valuable when a company is scaling its pet supplement production. A smaller initial order can reduce inventory risk, while larger repeat orders can improve unit economics. However, flexibility has limits. Very small batches may create disproportionately high setup, cleaning, testing, and packaging costs.

Lead times must also be evaluated realistically. Formula development, ingredient sourcing, sampling, revisions, stability work, label review, packaging production, laboratory testing, commercial manufacturing, and release are separate stages. A quoted production lead time may begin only after the formula, packaging artwork, deposit, and all required materials have been approved.

Brands can reduce delays by providing a complete product brief, confirming the destination market early, responding quickly to samples, finalizing packaging specifications, and avoiding repeated formula changes after scale-up has started.

3. Choosing a Pet Supplement Manufacturer and the Right Model for Your Brand

3.1 How to Evaluate Pet Supplement Manufacturers and Protect Brand Integrity

Choosing a pet supplement manufacturer involves more than comparing unit prices. The partner’s knowledge, manufacturing capabilities, quality standards, communication, documentation, capacity, and development process must match the brand’s specific needs.

A leading pet supplements manufacturer should be able to explain which delivery formats it produces, whether production is completed in its own facility, its standard and custom MOQ requirements, sample procedures, packaging options, testing capabilities, expected lead times, and available regulatory documentation.

The manufacturer should also be able to discuss formulation challenges rather than simply approve every proposed ingredient. For example, it should explain how heat may affect probiotics, how moisture can influence soft chews, how botanical ingredients may affect taste, or how high active-ingredient loads can affect chewable tablets.

Brands should ask whether the manufacturer can support both the initial launch and future production scale. Flexible batch sizes are useful, but the company should also understand how pricing, lead times, and packaging procurement will change as order volume grows.

Transparency around substitutions is essential for protecting brand integrity. A manufacturer should not replace an active ingredient, flavor, carrier, or packaging component without documented approval. The agreement should define formula ownership, confidentiality, specifications, approved suppliers, testing responsibilities, change control, and the handling of nonconforming products.

Pricing should be evaluated as a complete project cost rather than only a per-unit figure. Sampling, formulation work, laboratory testing, custom flavors, tooling, packaging, labels, cartons, freight, storage, and compliance review may be charged separately.

The best partner is not necessarily the company offering the lowest MOQ or shortest advertised lead time. It is the manufacturer capable of providing consistent quality, realistic communication, suitable technical solutions, and enough control to protect the brand as the business grows.

3.2 OEM or ODM: A Practical Decision Framework for New and Established Companies

For many new businesses, ODM or stock-formula private label pet supplements provide the most practical starting point. This model generally offers lower development risk, more predictable pricing, a manageable MOQ, and shorter lead times.

It allows the company to test a product category before investing heavily in custom development. The brand can learn whether its customers are more interested in joint health, gut health, calming support, skin and coat products, or personalized wellness solutions.

However, a new company should not select a product only because it has the lowest MOQ. The formula must still match the intended animals, customer needs, price point, brand promise, delivery format, and destination market.

OEM pet supplements become more appropriate when the company has identified a genuine gap or has sales data showing what customers want. Established companies may already understand which ingredients, formats, serving sizes, and pricing levels work for their market. They can use this knowledge to develop a differentiated formula with greater long-term value.

A hybrid approach is also possible. The company may begin with an established ODM base formula and make controlled adjustments to the flavor, active ingredients, concentration, packaging, or serving format. This provides more differentiation than a completely standard private label product without requiring every component to be developed from the beginning.

Over time, a brand may progress from a stock formula to a semi-custom solution and eventually to a fully customized OEM product. This phased process can protect cash flow, reduce early inventory risk, and allow product development decisions to be based on real customer behavior.

ODM supports speed, simplicity, and cost control. OEM supports deeper differentiation, formulation control, and potentially stronger product ownership. Both models can produce successful, high-quality supplements when they are supported by responsible formulation, appropriate safety standards, verified materials, effective quality assurance, suitable packaging, and honest communication with consumers.

The final decision should begin with a clear product brief. The company should define its target pets, intended wellness outcome, customer profile, preferred supplement type, delivery format, active ingredients, target price, expected sales volume, launch schedule, destination market, and acceptable MOQ.

With these details in place, the business can evaluate pet supplement manufacturers based on their ability to meet actual customer needs—not simply on a low advertised price or an unrealistic promise of immediate production. The right contract manufacturing partner should help the brand launch responsibly, maintain quality, respond to changing consumer preferences, and expand production as the business achieves long-term success.